MOH vs. HUM, CNC, UNH, ELV, CI, OSCR, ALHC, TRUP, CLOV, and NEUE
Should you be buying Molina Healthcare stock or one of its competitors? The main competitors of Molina Healthcare include Humana (HUM), Centene (CNC), UnitedHealth Group (UNH), Elevance Health (ELV), The Cigna Group (CI), Oscar Health (OSCR), Alignment Healthcare (ALHC), Trupanion (TRUP), Clover Health Investments (CLOV), and NeueHealth (NEUE). These companies are all part of the "hospital & medical service plans" industry.
Humana (NYSE:HUM) and Molina Healthcare (NYSE:MOH) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability, institutional ownership and community ranking.
Humana has higher revenue and earnings than Molina Healthcare. Molina Healthcare is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.
In the previous week, Molina Healthcare had 2 more articles in the media than Humana. MarketBeat recorded 43 mentions for Molina Healthcare and 41 mentions for Humana. Humana's average media sentiment score of 0.31 beat Molina Healthcare's score of 0.24 indicating that Molina Healthcare is being referred to more favorably in the news media.
92.4% of Humana shares are owned by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are owned by institutional investors. 0.3% of Humana shares are owned by insiders. Comparatively, 1.1% of Molina Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Humana has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500. Comparatively, Molina Healthcare has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500.
Humana received 353 more outperform votes than Molina Healthcare when rated by MarketBeat users. Likewise, 63.90% of users gave Humana an outperform vote while only 57.05% of users gave Molina Healthcare an outperform vote.
Humana presently has a consensus price target of $402.60, indicating a potential upside of 2.54%. Molina Healthcare has a consensus price target of $376.18, indicating a potential upside of 12.17%. Given Humana's stronger consensus rating and higher probable upside, analysts plainly believe Molina Healthcare is more favorable than Humana.
Molina Healthcare has a net margin of 2.84% compared to Molina Healthcare's net margin of 1.82%. Humana's return on equity of 29.17% beat Molina Healthcare's return on equity.
Summary
Molina Healthcare beats Humana on 13 of the 19 factors compared between the two stocks.
Get Molina Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for MOH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MOH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Molina Healthcare Competitors List
Related Companies and Tools
